Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.23.1
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 990 $ 3,594
Prepaid expenses and other assets 471 445
Total Assets 1,461 4,039
Current Liabilities:    
Accounts payable and accrued expenses (includes related party $1 and $2 respectively) 2,320 1,665
Total Liabilities 2,320 1,665
Commitments
Stockholders’ Equity (Deficit)    
Preferred stock - $0.0001 par value; 10,000,000 authorized; 0 shares outstanding at March 31, 2023 and December 31, 2022 0 0
Common stock - $0.0001 par value; 100,000,000 shares authorized; 8,227,074 and 8,009,743 shares issued and outstanding at March 31, 2023 and December 31, 2022 1 1
Additional paid in capital 25,462 24,559
Accumulated deficit (26,322) (22,186)
Total Stockholders’ Equity (Deficit) (859) 2,374
Total Liabilities and Stockholders’ Equity and (Deficit) $ 1,461 $ 4,039